Chugai Pharmaceutical Co Stock Today
| CHGCF Stock | USD 41.07 1.77 4.50% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Chugai Pharmaceutical is trading at 41.07 as of the 27th of November 2024. This is a 4.50 percent increase since the beginning of the trading day. The stock's lowest day price was 40.91. Chugai Pharmaceutical has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Chugai Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of May 2024 and ending today, the 27th of November 2024. Click here to learn more.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. The company has 1.64 B outstanding shares. More on Chugai Pharmaceutical Co
Moving together with Chugai Pink Sheet
| 0.71 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.66 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.68 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.66 | RHHBY | Roche Holding | PairCorr |
| 0.61 | RHHVF | Roche Holding AG | PairCorr |
Moving against Chugai Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Chugai Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Chugai Pharmaceutical Co [CHGCF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 44.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chugai Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.64 B outstanding shares.
Chugai Pharmaceutical Co has accumulated about 545.3 B in cash with 279.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 331.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Chugai Pharmaceutical Probability Of Bankruptcy
Ownership AllocationChugai Pharmaceutical holds a total of 1.64 Billion outstanding shares. Chugai Pharmaceutical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Chugai Ownership Details
Chugai Pharmaceutical Risk Profiles
| Mean Deviation | 2.22 | |||
| Standard Deviation | 4.44 | |||
| Variance | 19.73 | |||
| Risk Adjusted Performance | (0.02) |
Chugai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chugai Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Chugai Pharmaceutical Corporate Directors
| Shinji Hidaka | Executive Officer, Deputy Chief Director of Sales, Manager of Primary Unit | Profile | |
| Osamu Okuda | Executive Officer, Director of Business Planning | Profile | |
| Yoshiaki Ohashi | Executive Officer, Chief Director of Drug Safety, Manager of Regulatory & Quality Management Unit | Profile | |
| Tetsuya Yamaguchi | Executive Officer, Director of Business Development | Profile |
Other Information on Investing in Chugai Pink Sheet
Chugai Pharmaceutical financial ratios help investors to determine whether Chugai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chugai with respect to the benefits of owning Chugai Pharmaceutical security.